Received Mar 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | — |
Allergy to pneumovax; This spontaneous report was received from a consumer referring to an 80-year-old female patient. The patient's Historical drugs included Phenoxymethylpenicillin potassium (PENICILLIN VK), Influenza vaccine rHA 3v (baculovirus) (FLUBLOK), Chlorpheniramine, Morphine sulfate, Acetaminophen (Paracetamol), Acyclovir, Chlorphenamine maleate (+) Paracetamol (+) Phenylephrine hydrochloride (DRISTAN COLD MULTI-SYMPTOM FORMULA), Xylometazoline hydrochloride (SUDAFED), Pethidine hydrochloride (MEPERIDINE HCl), and Sulfamethoxazole (+) Trimethoprim (SULFAMETHOPRIM). Concurrent condition was not reported. On an unknown date, the patient was vaccinated with a dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) solution for injection (Lot #, expiration date, dose, strength, anatomical location of vaccine and route of administration were not reported) for prophylaxis. On an unknown date, the patient experienced Allergy to pneumovax. At the reporting time, the outcome of Allergy to pneumovax was unknown. On an unknown date in 2024, the patient started therapy with sotatercept (WINREVAIR) injection (strength, dose, frequency, lot#, expiry date, route and indication were not reported). On an unknown date in 2024, the patient experienced nosebleed (Captured on Case # 2055804). The reporter considered the event of Allergy to pneumovax to be related to Pneumococcal Vaccine, Polyvalent (23-valent). Lot # is being requested and will be submitted if reported. This is one of the two reports from the same reporter.